PCV69 CONVENIENCE OF THE NEW LONG-ACTING ANTICOAGULANT IDRAPARINUX VERSUS VITAMIN K ANTAGONIST IN PATIENTS WITH ATRIAL FIBRILLATION
May 1, 2008, 00:00
10.1016/S1098-3015(10)70655-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)70655-0/fulltext
Title :
PCV69 CONVENIENCE OF THE NEW LONG-ACTING ANTICOAGULANT IDRAPARINUX VERSUS VITAMIN K ANTAGONIST IN PATIENTS WITH ATRIAL FIBRILLATION
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70655-0&doi=10.1016/S1098-3015(10)70655-0
First page :
Section Title :
Open access? :
No
Section Order :
390